Published in Lancet on September 16, 1995
Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study. Aliment Pharmacol Ther (2009) 1.19
The de ritis ratio: the test of time. Clin Biochem Rev (2013) 1.14
Review and Recommendations for the Component Tests in the Liver Function Test Profile. Indian J Clin Biochem (2015) 0.75
Alcohol consumption. Lancet (1995) 0.75
Mortality from asthma: a new epidemic in New Zealand. Br Med J (Clin Res Ed) (1982) 6.78
Asthma mortality in New Zealand: a two year national study. N Z Med J (1985) 4.60
Trends in sales of drugs for asthma in New Zealand, Australia, and the United Kingdom, 1975-81. Br Med J (Clin Res Ed) (1984) 4.46
Recovery of motor function after stroke. Stroke (1988) 4.31
A case-control study of deaths from asthma. Thorax (1986) 3.97
Management of raised blood pressure in New Zealand: a discussion document. BMJ (1993) 3.96
Passive smoking as well as active smoking increases the risk of acute stroke. Tob Control (1999) 3.91
Differences between respondents and nonrespondents in a multicenter community-based study vary by gender ethnicity. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. J Clin Epidemiol (1996) 3.49
International trends in asthma mortality: 1970 to 1985. Chest (1988) 2.97
Accuracy of certification of deaths due to asthma. A national study. Am J Epidemiol (1986) 2.74
Underestimation of relative weight by use of self-reported height and weight. Am J Epidemiol (1987) 2.62
Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol (1990) 2.46
Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993. Circulation (2000) 2.45
Evidence-based management of dyslipidaemia. Lancet (1995) 2.29
Trends in coronary heart disease mortality and associated risk factors in New Zealand. N Z Med J (1981) 2.19
The real contribution of the major risk factors to the coronary epidemics: time to end the "only-50%" myth. Arch Intern Med (2001) 2.15
The changing global context of public health. Lancet (2000) 2.02
Globalization and health: a framework for analysis and action. Bull World Health Organ (2001) 2.00
International trends in stroke mortality: 1970-1985. Stroke (1990) 1.97
Medical management and the decline in mortality from coronary heart disease. Br Med J (Clin Res Ed) (1986) 1.81
Alcohol consumption and risk of coronary heart disease. BMJ (1991) 1.74
Asthma mortality: comparison between New Zealand and England. Br Med J (Clin Res Ed) (1986) 1.69
A review of the evidence concerning the impact of medical measures on recent mortality and morbidity in the United States. Int J Health Serv (1989) 1.59
Cholesterol and mortality in New Zealand Maoris. Br Med J (1980) 1.58
Death from asthma in Auckland: circumstances and validation of causes. N Z Med J (1984) 1.51
Event, incidence and case fatality rates of cerebrovascular disease in Auckland, New Zealand. Am J Epidemiol (1984) 1.51
Changes in stroke incidence and case-fatality in Auckland, New Zealand, 1981-91. Lancet (1993) 1.46
[Answers to 10 questions. Passive smoking and coronary disease]. Lakartidningen (1993) 1.40
Strategies for reducing the drug bill. N Z Med J (1989) 1.40
Should we prescribe exercise? N Z Med J (1989) 1.40
The Auckland diet: results from a seven day food diary. N Z Med J (1991) 1.38
Cardiovascular disease epidemiology in developing countries: ethics and etiquette. Lancet (1994) 1.38
Deaths from asthma in New Zealand. Arch Dis Child (1986) 1.36
Trends in dietary fat and cigarette smoking and the decline in coronary heart disease in New Zealand. Int J Epidemiol (1987) 1.36
Does treatment of hypertension explain the decline in mortality from stroke? Br Med J (Clin Res Ed) (1986) 1.30
A longitudianl study of blood pressure in Polynesian children. Am J Epidemiol (1977) 1.29
Cardiovascular disease in developing countries. BMJ (1992) 1.29
Lessons from the national asthma mortality study: circumstances surrounding death. N Z Med J (1987) 1.26
The validity of Maori mortality statistics. N Z Med J (1989) 1.26
Asthma morbidity and mortality: New Zealand. J Allergy Clin Immunol (1987) 1.25
Cigarette smoking and risk of premature stroke in men and women. Br Med J (Clin Res Ed) (1986) 1.24
Serum cholesterol, diet, and the decline in coronary heart disease mortality. Prev Med (1979) 1.24
Level, trend, and variability of blood pressure during childhood: the Muscatine study. Circulation (1984) 1.23
Coronary heart disease and elderly people. BMJ (1991) 1.22
Does physical activity lower blood pressure: a critical review of the clinical trials. J Clin Epidemiol (1992) 1.19
Alcohol consumption and blood pressure. Am J Epidemiol (1985) 1.15
Blood pressure in Tokelauan children in two contrasting environments. Am J Epidemiol (1978) 1.11
Which hypertensive patients should be treated? Lancet (1994) 1.11
Validation of a three-month physical activity recall questionnaire with a seven-day food intake and physical activity diary. Epidemiology (1991) 1.09
Blood pressure levels and the treatment of hypertension in Auckland, 1982. N Z Med J (1983) 1.09
Factors related to tracking of blood pressure in children. U.S. National Center for Health Statistics Health Examination Surveys Cycles II and III. Hypertension (1984) 1.08
Explaining stroke mortality trends. Lancet (1993) 1.04
Challenges for public health in the global context--prevention and surveillance. Scand J Public Health (2001) 1.03
Variation in the time and day of onset of myocardial infarction and sudden death. N Z Med J (1995) 1.02
Blood pressure and migration in children. Int J Epidemiol (1979) 1.01
Secular trends in underreporting of cigarette consumption. Am J Epidemiol (1985) 0.99
Rapid reduction in coronary risk for those who quit cigarette smoking. Aust N Z J Public Health (1998) 0.99
Trends in coronary heart disease mortality and morbidity in Auckland, New Zealand, 1974-1986. Int J Epidemiol (1990) 0.98
Does recent alcohol consumption reduce the risk of acute myocardial infarction and coronary death in regular drinkers? Am J Epidemiol (1992) 0.97
Comparison of case fatality in smokers and non-smokers after acute cardiac event. BMJ (1997) 0.96
Trends in coronary heart disease event rates in New Zealand. Am J Epidemiol (1984) 0.96
Trends in coronary heart disease risk factors in Auckland 1982-94. N Z Med J (1995) 0.96
The relationships of diabetes, blood lipids, and uric acid levels in Polynesians. Adv Metab Disord (1978) 0.95
Asthma mortality: a review of recent experience in New Zealand. J Allergy Clin Immunol (1987) 0.95
Science, advocacy and health policy: lessons from the New Zealand tobacco wars. J Public Health Policy (1991) 0.94
Approaches to the problems of measuring the incidence of stroke: the Auckland Stroke Study, 1991-1992. Int J Epidemiol (1995) 0.93
The long-term monitoring of cardiovascular disease: is it feasible? Community Health Stud (1983) 0.93
Relations of changes in coronary disease rates and changes in risk factor levels: methodological issues and a practical example. Am J Epidemiol (1996) 0.92
Alcohol and exercise in myocardial infarction and sudden coronary death in men and women. Am J Epidemiol (1987) 0.91
Coronary heart disease in Maoris: incidence and case mortality. N Z Med J (1978) 0.90
Health promotion: can it redress the health effects of social disadvantage? Community Health Stud (1989) 0.90
Subarachnoid hemorrhage in New Zealand: an epidemiological study. Stroke (1984) 0.90
Salt restriction and physical activity in treated hypertensives. N Z Med J (1995) 0.90
The longevity of international rugby players. N Z Med J (1983) 0.90
Plasma high-density lipoprotein cholesterol: association with measurements of body mass. The Lipid Research Clinics Program Prevalence Study. Circulation (1980) 0.89
Epidemiology of varicose veins. World J Surg (1986) 0.89
Grading of evidence of the effectiveness of health promotion interventions. J Epidemiol Community Health (2008) 0.89
Monitoring stroke. An international challenge. Stroke (1995) 0.89
Trends in survival after myocardial infarction in New Zealand, 1974-81. Lancet (1984) 0.87
A controlled smoking intervention programme in secondary schools. N Z Med J (1978) 0.86
The challenge for Beijing: the 10th world conference on tobacco or health. BMJ (1997) 0.85
The enigma of the decline in stroke deaths in the United States: the search for an explanation. Stroke (1996) 0.85
Coronary events and exposure to environmental tobacco smoke: a case-control study from Australia and New Zealand. Tob Control (1998) 0.85
Validation of coronary heart disease death certificate diagnoses. N Z Med J (1988) 0.85
Coronary heart disease mortality, morbidity, and risk factor trends in New Zealand. Cardiology (1985) 0.84
Lessons from the national asthma mortality study: deaths in hospital. N Z Med J (1987) 0.84
Cigarette smoking habits, attitudes and associated social factors in adolescents. N Z Med J (1978) 0.83
Ethnic differences in stroke incidence and case fatality in Auckland, New Zealand. Stroke (1997) 0.83
An epidemiological study of left ventricular hypertrophy in the biracial population of Evans County, Georgia. J Chronic Dis (1975) 0.82
Myocardial infarction and sudden death in Auckland. N Z Med J (1984) 0.82
Has the long term prognosis following myocardial infarction improved? N Z Med J (1986) 0.82
Increased treatment of hypertension does not explain the decline in stroke mortality in the United States, 1970-1980. Hypertension (1989) 0.81
Sudden death in runners. N Z Med J (1983) 0.81
Are low cholesterol values associated with excess mortality? Br Med J (Clin Res Ed) (1985) 0.80
Blood pressure and social interaction in Tokelauan migrants in New Zealand. J Chronic Dis (1977) 0.80
Trends in antihypertensive medication costs in a cohort of Aucklanders 1982-87. N Z Med J (1989) 0.80
Coronary heart disease mortality in Auckland Maori and Europeans. N Z Med J (1991) 0.80
Does passive smoking cause heart disease? BMJ (1990) 0.79